title: Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification.
authors.affiliation: Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.
authors.forename: William D
authors.initials: WD
authors.lastname: Travis
authors.affiliation: Department d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier, INSERM U823 Institut Albert Bonniot, Grenoble, France.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Brambilla
authors.affiliation: Department of Pathology, Royal Brompton Hospital, London, United Kingdom.
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Nicholson
mesh_terms: D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification*; D008297:Male; D014944:World Health Organization / Q000458:organization & administration*